Benzinga · Feb 2, 2026
SS Innovations International Files Prospectus For Offering 11.3M Common Shares
SEC Filing.
NASDAQ · SSII
Healthcare · Medical - Devices
$3.83
Up+$0.15 (+3.92%)
Updated Aug 14, 2026, 5:13 PM
SID Score
3.6/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 21 trading sessions · Daily adjusted prices
SSII closed at $3.83 after 21 trading sessions, up 6.09% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 13, 2026 | $3.70 | $3.97 | $3.70 | $3.83 | 48.05K |
| Aug 12, 2026 | $3.64 | $3.80 | $3.64 | $3.69 | 17.54K |
| Aug 11, 2026 | $3.77 | $3.78 | $3.60 | $3.61 | 9.08K |
| Aug 10, 2026 | $3.78 | $3.88 | $3.71 | $3.75 | 18.54K |
| Aug 7, 2026 | $3.75 | $3.795 | $3.62 | $3.77 | 37.12K |
| Aug 6, 2026 | $3.87 | $3.87 | $3.66 | $3.71 | 14.47K |
| Aug 5, 2026 | $3.90 | $3.935 | $3.60 | $3.85 | 109.22K |
| Aug 4, 2026 | $3.92 | $3.95 | $3.75 | $3.83 | 122.41K |
| Aug 3, 2026 | $4.00 | $4.00 | $3.875 | $3.95 | 17.47K |
| Jul 31, 2026 | $3.96 | $4.11 | $3.85 | $3.98 | 33.12K |
| Jul 30, 2026 | $4.00 | $4.06 | $3.75 | $3.99 | 60.74K |
| Jul 29, 2026 | $3.93 | $4.025 | $3.72 | $3.85 | 71.44K |
| Jul 28, 2026 | $4.05 | $4.1462 | $3.8561 | $3.93 | 109.25K |
| Jul 27, 2026 | $3.50 | $4.10 | $3.4014 | $3.96 | 239.58K |
| Jul 24, 2026 | $3.54 | $3.69 | $3.37 | $3.475 | 144.62K |
| Jul 23, 2026 | $3.51 | $3.9312 | $3.36 | $3.57 | 258.19K |
| Jul 22, 2026 | $3.61 | $3.725 | $3.48 | $3.58 | 16.6K |
| Jul 21, 2026 | $3.61 | $3.77 | $3.55 | $3.58 | 40.83K |
| Jul 20, 2026 | $3.62 | $3.86 | $3.46 | $3.75 | 52.91K |
| Jul 17, 2026 | $3.55 | $3.71 | $3.49 | $3.64 | 15.55K |
| Jul 16, 2026 | $3.50 | $3.63 | $3.4803 | $3.61 | 44.44K |
The latest Smart Investors Daily articles mentioning SSII.
SSII research
Company profile and research snapshot.
SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jun 3, 2026 | LUCID CAPITAL MARKETS | Buy | — |
No generated briefing is available yet.
Benzinga · Feb 2, 2026
SEC Filing.
Yahoo · Jan 15, 2026
SS Innovations International recently issued preliminary, unaudited guidance indicating fourth-quarter 2025 revenue of about US$15.0 million and full-year 2025 revenue of about US$43.0 million, both sharply higher than 2024 levels, alongside new product launches and senior leadership changes. An interesting angle for investors is the rapid build-out of the SSi Mantra surgical robot installed base, supported by new 5-millimeter instruments and an incoming Global Chief Operating Officer and...
Yahoo · Jan 14, 2026
SS Innovations International (SSII) has drawn investor attention after recent trading, with the stock up 10.8% over the past day and 2.8% over the past week, contrasting with a 33.9% decline over the past 3 months. See our latest analysis for SS Innovations International. That recent 1 day share price return of 10.84% at a share price of $5.93 stands against a 90 day share price return of 33.96% decline and a 1 year total shareholder return of 26.79% decline. This suggests short term momentum...
Yahoo · Jan 13, 2026
Anticipated strong revenue growth driven by higher unit sales of SSi Mantra surgical robotic systemFORT LAUDERDALE, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced preliminary unaudited revenue and other select operating metrics for the three and twelve months en
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning SSII.